New combo therapy aims to slow kidney disease in IgA patients
NCT ID NCT03188887
First seen Nov 20, 2025 · Last updated Apr 28, 2026 · Updated 19 times
Summary
This study tested whether adding early steroid treatment to standard blood pressure or diabetes medications can better control IgA nephropathy, a kidney disease. 62 adults with severe kidney damage on biopsy were randomly assigned to get either the combination or standard care alone. The goal was to see if the combo reduced protein in urine and preserved kidney function over two years.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for IGA NEPHROPATHY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Hôpital Necker Enfants-malades
Paris, Paris, 75015, France
Conditions
Explore the condition pages connected to this study.